The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Ramzi Musallam

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Ramzi Musallam is a private equity based in New York across 220 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Ramzi Musallam on Aerospace Defense, Cybersecurity and Edtech.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Ramzi Musallam — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Ramzi Musallam — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Ramzi Musallam — 220
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Ramzi Musallam — Aerospace Defense, Cybersecurity, Edtech

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Ramzi Musallam — Private Equity · New York · 220 tracked deals · Ramzi Musallam portfolio

Similar investors

• Marc K. Furstein
• Pal B. Ristvedt
• Harsha Marti
• Magnus Grimeland
• Daniel Fabian
• Victor L. Wu
• Fady Abdel-Nour
• Opto Custom GP 2023 LLC
• Thomas Teles
• Steven G. Glenn

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Ramzi Musallam · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory